(2017) doi: 10.5772/intechopen.68417 [DOI] 43.Hui JM, Hodge A, Farrell GC, Kench JG, Kriketos A, George J
During a median follow-up time of 1.4 years, 13 patients had recurrent ICH and 22 patients had an ischemic stroke
The goal of mB12 therapy is to support a process called methylation
The phase 3 trial is in 8,000+ patients with established cardiovascular disease and elevated Lp(a) with a hard primary endpoint composite of cardiovascular death, myocardial infarction, stroke, or urgent coronary revascularization requiring hospitalization
Moreover, due to the precision of the medication delivery, needleless injections can be advantageous in terms of dosage accuracy
Key Takeaways: 93.8% Encapsulation Efficiency Is the Benchmark WBCILs LipoEdge Glutathione achieves a validated encapsulation efficiency of 93.8% through precision high-pressure homogenisation and a 93% phospholipid bilayer composition